Abstract
Background
Extramammary Paget’s disease (EPD) is a cutaneous adenocarcinoma. It is usually curable by wide local excision. However, the prognosis for EPD patients with metastases is extremely poor because effective chemotherapy for advanced EPD has not been established.
Methods
We retrospectively analyzed the efficacy of combination chemotherapy consisting of infusions of 5-fluorouracil (5-FU, 600 mg/m2/body, 5 days/week) and cisplatin (5–10 mg/body, 5–7 days/week) administered intravenously for 8–24 h (low-dose FP).
Results
The patients were 15 males and 7 females and the ages ranged from 54 to 91 years old (median 71). The toxicities of low-dose FP were as follows: hematopoietic dysfunction (n = 4), gastrointestinal dysfunction (4), nephropathy (1), and phlebitis (1). Almost all toxicities were grade 1 or 2 except for 2 cases with grade 3 leukopenia or pancytopenia. Seventeen patients were treated with low-dose FP only, and the clinical results included 10 partial responses (PR), 4 stable disease (SD), and 3 progressive disease (PD). The overall survival ranges (medians) were 5–51 months (12) in all 22 patients, 6–51 months (13) in the 13 patients showing complete response or PR, and 5–12 months (11) in the 6 SD patients. The reported palliative effects of low-dose FP include control of pain and improvement of lymphedema.
Conclusion
Although the number of cases is limited and there is a bias because cases without clinical effects are less likely to be reported, this regimen might be considered a relatively effective option for advanced EPD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tokuda Y, Oguchi S, Yamazaki Y et al (1997) Low dose FP (5-FU + low-dose CDDP) therapy for advanced extramammary Paget’s disease. Jpn J Dermatol 107:21–27 (in Japanese)
Uhara H, Saida T (2003) Chemotherapy and immunotherapy for extramammary Paget’s disease and sweat gland carcinoma. Skin Cancer 18:92–98 (in Japanese)
Morita R, Kinbara T, Hatta N et al (1999) Low-dose FP therapy response in advanced extramammary Paget’s disease: a case report. Rinsyo Derma 41:1475–1477 (in Japanese)
Oguchi S, Kaneko M, Uhara H et al (2002) Docetaxel induced durable response in advanced extramammary Paget’s disease: a case report. J Dermatol 29:33–37
Mastuura A, Katakami C, Okuda F et al (2002) A case of extramammary Paget’s carcinoma with large tumor. Skin Cancer 17:189–192 (in Japanese)
Onishi I, Kamata T, Hayashi H et al (2002) A case of vulvar extramammary Paget’s disease associated with pancreatic cancer that was successfully treated with chemotherapy. Jpn Cancer Chemother 29:1973–1976 (in Japanese)
Uemura M, Mukai M, Fukuhara S et al (2002) A case of extramammary Paget’s disease with anuria. Acta Urol Jpn 48:311–314 (in Japanese)
Otani T, Endo S, Kato H et al (2003) A case of extramammary Paget’s carcinoma showing responsive to biochemical modulation chemotherapy. J Tokyo Women Med Univ 73:99–104
Inui S, Fukuhara S, Asada H et al (2000) Double involvement of extramammary Paget’s disease in genitalia and axilla. J Dermatol 27:409–412
Osawa R, Aoyagi S, Sawamura D et al (2005) A case of advanced extrramammary Paget’s carcinoma treated with low-dose FP (5-FU + CDDP) therapy and simultaneous radiotherapy. Skin Cancer 20:79–82 (in Japanese)
Ishizawa T, Konno T (2002) A case of extramammary Paget’s carcinoma whose chief complaint was reddening swelling on the left leg. Skin Cancer 17:234–237 (in Japanese)
Yokouchi M, Kobayashi M, Inazumi T (2007) A case of advanced axillary Paget’s disease. Rinsyo Hifuka 61:554–557 (in Japanese)
Kikuchi Y, Akita M, Kato S et al (2004) A case of advanced extramammary Paget’s disease treated with low-dose FP and internal PDT therapy. Jpn J Dermatol 114:1443 (in Japanese)
Kariya K, Tsuji T, Schwartz RA (2004) Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget’s disease. Dermatol Surg 30:341–344
Harasima T, Sinokawa Y, Himi Y (2007) The experience of treatment of recurrence extramammary Paget’s disease by low-dose FP therapy. J Jpn P R S 27:535 (in Japanese)
Shibuya Y, Arakawa C, Suzuki S et al (2008) Low-dose FP: an effective treatment of advanced extramammary Paget’s disease. Skin Cancer 23:375–378 (in Japanese)
Yamamoto A, Yoneyama K, Ono S et al (2010) A case of secondary extramammary Paget’s disease. Tokyo J Obstet Gynecol 59:78–82 (in Japanese)
Yamada N, Kusakabe S, Tukamoto K et al (2010) Three cases of advanced extramammary Paget’s disease treated by chemo–radio therapy. Jpn J Dermatol 120:728 (in Japanese)
Hatta N, Yamada T, Hirono T et al (2008) Extramammary Paget’s disease: treatment, prognostic factors and outcome in 76 patients. Br J Dermatol 158:313–318
Yokoyama Y, Mabuchi M, Kawabata I et al (1990) Metastatic vulvar Paget’s disease responding to combination chemotherapy. Jpn J Clin Oncol 20:426–430
Yamazaki N, Yamamoto A, Wada T et al (1999) A case of metastatic extramammary Paget’s disease that responded to combination chemotherapy. J Dermatol 26:311–316
Kurooka S, Namikawa K, Tsutsumida A et al (2012) A statistical study of 101 patients with extramammary Paget’s disease. Jpn J Dermatol 122:2891–2897 (in Japanese)
Mkoshiba Y, Uhara H, Kubo H et al (2013) S-1 induced a durable response in metastatic extramammary Paget’s disease. J Dermatol 40:664–665
Acknowledgments
This study was supported in part by a National Cancer Center Research and Development Fund (23-A-22).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Tokuda, Y., Arakura, F. & Uhara, H. Combination chemotherapy of low-dose 5-fluorouracil and cisplatin for advanced extramammary Paget’s disease. Int J Clin Oncol 20, 194–197 (2015). https://doi.org/10.1007/s10147-014-0686-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-014-0686-2